Rifampin
Back to searchMolecule Structure
Scientific Name
Rifampin
Description of the Drug
Rifampicin is an antibiotic used to treat several types of mycobacterial infections including Mycobacterium avium complex, leprosy, and in combination with other antibacterials to treat latent or active tuberculosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01045
http://www.drugbank.ca/drugs/DB01045
Brand Name(s)
Eremfat, Rifadin, Rifampicin, Rifampin, Rimactane
Company Owner(s)
Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Lupin Pharmaceuticals Inc, Hikma International Pharmaceuticals Llc, Oxford Pharmaceuticals Llc, Hikma Pharmaceuticals Usa Inc, Epic Pharma Inc, Watson Pharmaceuticals Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Hikma Pharmaceuticals, Emcure Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial DNA-directed RNA polymerase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2364672 |
Clinical Trial(s)
Unichem Links
| Atlas | rifampicin | |
| SureChEMBL | SCHEMBL23490 | |
| DrugBank | DB01045 | |
| PubChem: Thomson Pharma | 14865086 | 14791501 |
| PubChem | 136262914 | 135398735 |
| LINCS | LSM-43162 | |
| PDBe | RFP | |
| BindingDB | 50370232 | |
| EPA CompTox Dashboard | DTXSID6021244 | |
| Metabolights | MTBLC71365 | MTBLC28077 |
| Rhea | 71365 | |
| ChemicalBook | CB7474473 | |
| Guide to Pharmacology | 2765 | |
| rxnorm | RIFAMPIN | RIFADIN |
| PubChem: Drugs of the Future | 24714737 | |
| KEGG Ligand | C06688 | |
| ChEBI | 28077 | 71365 |
| ZINC | ZINC000169621223 |
